Keyphrases
Hypofractionated Radiotherapy
100%
Orthotopic Model
100%
Anaplastic Thyroid Cancer
100%
Conventional Fractionation
100%
Response to Radiation
50%
Thyroid Cancer Cell Lines
33%
Response Rate
16%
Cancer Tumor
16%
Tumor Growth
16%
Gene Expression Profiling
16%
Chemotherapy Response
16%
Metastatic Spread
16%
Overall Survival
16%
Poor Outcome
16%
Recent Advances
16%
Radiation Therapy
16%
Distant Metastasis
16%
Cancer Model
16%
Median Time
16%
Radioresistant Cells
16%
Radiotherapy
16%
Local Control
16%
Patient Selection
16%
Radiosensitivity
16%
Cellular Response
16%
C-X-C Chemokine Receptor Type 4 (CXCR4)
16%
Microarray Gene Expression
16%
Combined Modality Therapy
16%
Radiation Chemotherapy
16%
Tumor Growth Delay
16%
Therapy Response
16%
Radiation Response
16%
Bioluminescence Imaging
16%
Personalized Therapy
16%
Clinical Trial Design
16%
Lethal Infection
16%
Clonogenic Assay
16%
Fractionation Schedules
16%
Time to Progression
16%
Resistance to Therapy
16%
Regional Metastasis
16%
Radioresistant
16%
Radiosensitive
16%
Radioresistance
16%
Conventional Radiotherapy
16%
Conventionally Fractionated Radiotherapy
16%
Test Alternative
16%
Radiotherapy Fractionation
16%
Metastatic Survival
16%
Medicine and Dentistry
Hypofractionated Radiotherapy
100%
Anaplastic Thyroid Carcinoma
100%
Radiation Therapy
83%
Tumor Progression
33%
Radiosensitivity
33%
Thyroid Cancer Cell Line
33%
Gene Expression Profiling
16%
Clinical Trial
16%
Overall Survival
16%
Ex Vivo
16%
Personalized Medicine
16%
Distant Metastasis
16%
Tumor
16%
Cell Line
16%
Tumor Model
16%
Patient Selection
16%
DNA Microarray
16%
Radiation Response
16%
Regional Metastasis
16%
Clonogenic Assay
16%
Bioluminescence
16%
Diseases
16%
Radioresistant Cell Line
16%